Teva Pharmaceutical Industries Total Long Term Liabilities 2010-2024 | TEVA

Teva Pharmaceutical Industries total long term liabilities for the quarter ending June 30, 2024 were $21.737B, a 7.67% decline year-over-year.

  • Teva Pharmaceutical Industries total long term liabilities for 2023 were $23.106B, a 3.5% decline from 2022.
  • Teva Pharmaceutical Industries total long term liabilities for 2022 were $23.945B, a 5.71% decline from 2021.
  • Teva Pharmaceutical Industries total long term liabilities for 2021 were $25.395B, a 3.86% decline from 2020.

Teva Pharmaceutical Industries Total Long Term Liabilities 2010-2024 | TEVA

  • Teva Pharmaceutical Industries total long term liabilities for 2023 were $23.106B, a 3.5% decline from 2022.
  • Teva Pharmaceutical Industries total long term liabilities for 2022 were $23.945B, a 5.71% decline from 2021.
  • Teva Pharmaceutical Industries total long term liabilities for 2021 were $25.395B, a 3.86% decline from 2020.
Related Stocks
Company NameMarket
Cap
Dr Reddy's Laboratories (RDY)$13.1B
BridgeBio Pharma (BBIO)$5B
Bausch Health Cos (BHC)$3B
Amphastar Pharmaceuticals (AMPH)$2.4B
Supernus Pharmaceuticals (SUPN)$1.8B
Taysha Gene Therapies (TSHA)$449M
Personalis (PSNL)$315M
Assembly Biosciences (ASMB)$117M
Acasti Pharma (ACST)$28M
Sol-Gel Technologies (SLGL)$20M
Evoke Pharma (EVOK)$4M
Teligent (TLGT)$0M